Last reviewed · How we verify
A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.
To evaluate the effectiveness, safety and pharmacokinetics of TQH2722 injection in patients with chronic sinusitis with or without nasal polyps.
Details
| Lead sponsor | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. |
|---|---|
| Phase | PHASE2 |
| Status | COMPLETED |
| Enrolment | 160 |
| Start date | Thu Dec 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Apr 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Sinusitis
Interventions
- 300mg of TQH2722 injection
- 600mg of TQH2722 injection
- TQH2722 injection matching placebo
Countries
China